Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis.
about
Perlecan controls neurogenesis in the developing telencephalonProteoglycan form and function: A comprehensive nomenclature of proteoglycansPerlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesisDevelopmentally regulated expression and localization of fibroblast growth factor receptors in the human muscleEndorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cellsFibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblastsComparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenanceSyndecans: multifunctional cell-surface co-receptorsHeparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts.Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasiaAntisense targeting of perlecan blocks tumor growth and angiogenesis in vivoSuppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNAA central function for perlecan in skeletal muscle and cardiovascular developmentPerlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactionsExpression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cellsPerlecan maintains the integrity of cartilage and some basement membranesExpression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitroCytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord InjuryThe role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagyInsidious changes in stromal matrix fuel cancer progressionStructure and stability of an acidic fibroblast growth factor from Notophthalmus viridescensExtracellular Matrix, a Hard Player in AngiogenesisPivotal role for decorin in angiogenesisFibroblast growth factor-binding protein is a novel partner for perlecan protein coreThe protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7Spatial and temporal expression of perlecan in the early chick embryoDevelopmental expression of perlecan during murine embryogenesisThe C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycansTranscriptional silencing of perlecan gene expression by interferon-gammaFunctional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycansHuman ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitorThe degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanasesRelationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculatureEssential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesisStructural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding elementHeparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomasSyndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid
P2860
Q21284139-071E50FE-A228-4B37-8842-EE2C3CF15506Q21710680-665DA776-BFAC-48B1-A975-2C14DC8D8F7BQ24295251-5660D7AF-12D4-4C1A-AE1A-DBD1FE2BF1F7Q24311344-EC4665D3-A8E6-4843-9D0E-EF5A7F817EB7Q24312922-41DB84DC-04D7-4B0D-AB86-E6CFC1FAEEC2Q24329137-F84B27CD-065C-4069-9758-1C1FED0E89B8Q24339581-0D05753B-0830-4FC2-87A8-B36CBC23E92FQ24530478-B2AFB748-F7F1-4A34-A84F-60BD9C5D01C2Q24540314-32E2AF09-58AE-49F5-B778-B16965135A02Q24540423-2229D95B-29B6-4F0F-B67B-E4FCC6D7696AQ24561731-51B25C1E-5A36-4B65-A547-0A0771BFEFC2Q24563749-09575EB9-67FE-4EC5-8370-6FE837131E31Q24564477-AAE4BC18-B817-46A0-91A5-F0263D5C90BCQ24646731-12EFBA62-153E-4949-9832-90CD59D27098Q24648227-C14FEC8E-60A3-4306-90E2-F63E2C0A07DAQ24653433-E0E8CDD3-79FB-4982-AE26-E40D911EB0B3Q24654102-F7559395-315D-476B-8E0C-991D31427E73Q24675872-9557D51C-4FD4-474A-A415-A0CBFF44520FQ24680954-94D232D4-A96F-4E82-A2BF-E0DFBD394522Q24682147-13D56E22-B2E0-4F3E-9B10-790E1AA747E0Q26740237-62DAC2F6-12FF-418F-8F6B-5B5841CE910EQ26800258-7F4ABE6F-71D6-4DD5-8003-B8D0361230F8Q26851261-09B7C3C1-4064-4053-8890-886BCDCC81EAQ27639562-11989EE5-0552-467A-B8A3-6AA83AC04257Q28072886-C16494FD-E579-41F5-8393-918713649E4EQ28085303-292EC282-E98F-491C-A58B-753C102F112DQ28142123-229728E1-3E03-48A9-A255-CE241B883751Q28145823-EDB907D6-5467-4224-932F-C2A94EBBB29EQ28245112-2F025C1B-A4DE-4C81-A9D6-87CC1D11DC47Q28251854-F8864BCA-4A99-45B6-8D20-2559B8809304Q28259215-C3A4388C-360A-42A0-8718-3F44C2EC2FF3Q28262244-7FDA30BA-A673-4A09-91AD-4F7A716C81ADQ28270045-A8F808E1-A8B5-4A2C-8049-25113317C233Q28277631-62894F61-41F3-449C-901A-D5ACA6D4738FQ28278296-7EB03F25-C4E4-4BE5-AC35-317DBEF450BCQ28292534-C9DAA19D-DE9A-4632-A76F-8F76438D740AQ28294512-B6868FFC-3DCB-44E6-824A-FD67E37897D7Q28303522-6F336441-7543-45FE-BD6C-DA6433CA4F9CQ28344801-E042062B-B1EE-4091-B209-5617C120FF4FQ28510430-F4B1A06E-B341-408F-B549-15980A02E4BC
P2860
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Perlecan, basal lamina proteog ...... mitogenesis, and angiogenesis.
@en
Perlecan, basal lamina proteog ...... mitogenesis, and angiogenesis.
@nl
type
label
Perlecan, basal lamina proteog ...... mitogenesis, and angiogenesis.
@en
Perlecan, basal lamina proteog ...... mitogenesis, and angiogenesis.
@nl
prefLabel
Perlecan, basal lamina proteog ...... mitogenesis, and angiogenesis.
@en
Perlecan, basal lamina proteog ...... mitogenesis, and angiogenesis.
@nl
P2093
P1433
P1476
Perlecan, basal lamina proteog ...... mitogenesis, and angiogenesis.
@en
P2093
P304
P356
10.1016/0092-8674(94)90031-0
P407
P577
1994-12-01T00:00:00Z